Presentations

Tenosynovial Giant Cell Tumor


Presentations


Speakers

  • John H. Healey, MD

    John H. Healey, MD

    John H. Healey, MD

    Chief, Orthopaedic Surgery

    John H. Healey, MD, is chief, Orthopaedic Service, and the Stephen McDermott Chair in Surgery at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. Dr Healey in an orthopaedic surgeon specializing in caring for people with sarcomas and noncancerous tumors of the bones and soft tissue. He holds special interest in treating childhood bone cancers, such as osteosarcoma and Ewing sarcoma, and has expertise in removing tumors while preserving limbs. Dr Healey has maintained a funded research laboratory for 30 years to define the genetic causes of sarcomas and enhance drug delivery to tumors, has developed new surgical implants, holds multiple devise patents and has authored over 450 peer-reviewed scientific manuscripts and chapters.
  • Kristen Neuhaus

    Kristen Neuhaus

    Kristen Neuhaus

    Kristen Neuhaus, PharmD, a pharmacist from Cleveland, Ohio, graduated with her doctor of pharmacy degree from Northeast Ohio Medical University in Rootstown. One month prior to graduating, and two months before beginning her PGY-1 residency training, she was diagnosed with giant cell tumor (GCT) of the bone. Despite her diagnosis, she completed her PGY-1 residency. She began a second year of training in solid organ transplant, during which a giant cell tumor had reoccurred and spread to her soft tissue and surrounding joint. After her recovery from her most recent surgery, including a knee replacement and partial tibia replacement, Kristen plans to return to work as a pharmacist with a greater appreciation and understanding of how to navigate a difficult diagnosis as a patient.
  • William D. Tap, MD

    William D. Tap, MD

    William D. Tap, MD

    Chief, Sarcoma Medical Oncology Service

    William D. Tap, MD, is the chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. Dr Tap has extensive experience in translational medicine and is currently in charge of the clinical, basic science, and translational aspects of the Sarcoma Medical Oncology Program at MSKCC. He received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania, completed his internal medicine residency at the Vanderbilt University Medical Center in Nashville, Tennessee, and a fellowship in hematology and medical oncology at the UCLA Medical Center in Los Angeles, California. Dr Tap also has a tremendous interest in Global Health Initiatives; specifically, in effecting health disparity in underserved areas of the world.